Literature DB >> 33497830

New perspectives in oral peptide delivery.

Alessandra T Zizzari1, Dimanthi Pliatsika1, Flavio M Gall1, Thomas Fischer1, Rainer Riedl2.   

Abstract

Owing to their structural diversity, peptides are a unique source of innovative active ingredients. However, their development has been challenging because of their disadvantageous pharmacokinetic (PK) properties. Over the past decade, many attempts have been made to improve the oral bioavailability of peptide drugs. In this review, we highlight the most recent and promising techniques aimed at the improvement of the oral bioavailability of peptides. The most recent findings will influence future approaches of pharmaceutical companies in the development of new, more efficient, and safer orally delivered peptides.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33497830     DOI: 10.1016/j.drudis.2021.01.020

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  9 in total

Review 1.  Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV.

Authors:  Disha Panchal; Jeena Kataria; Kamiya Patel; Kaytlyn Crowe; Varun Pai; Abdul-Rahman Azizogli; Neil Kadian; Sreya Sanyal; Abhishek Roy; Joseph Dodd-O; Amanda M Acevedo-Jake; Vivek A Kumar
Journal:  Adv Ther (Weinh)       Date:  2021-08-06

Review 2.  Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies.

Authors:  Guanyu Chen; Weirong Kang; Wanqiong Li; Shaomeng Chen; Yanfeng Gao
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

3.  Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease.

Authors:  Sergei Pechenov; Jefferson Revell; Sarah Will; Jacqueline Naylor; Puneet Tyagi; Chandresh Patel; Lihuan Liang; Leo Tseng; Yue Huang; Anton I Rosenbaum; Kemal Balic; Anish Konkar; Joseph Grimsby; J Anand Subramony
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

4.  Pep19 Has a Positive Effect on Insulin Sensitivity and Ameliorates Both Hepatic and Adipose Tissue Phenotype of Diet-Induced Obese Mice.

Authors:  Renata Silvério; Robson Barth; Andrea S Heimann; Patrícia Reckziegel; Gustavo J Dos Santos; Silvana Y Romero-Zerbo; Francisco J Bermúdez-Silva; Alex Rafacho; Emer S Ferro
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

5.  Peptide-Based Drug Development.

Authors:  William D Lubell
Journal:  Biomedicines       Date:  2022-08-21

Review 6.  A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.

Authors:  Vanita R Aroda; Lawrence Blonde; Richard E Pratley
Journal:  Rev Endocr Metab Disord       Date:  2022-07-15       Impact factor: 9.306

7.  Facilitated Buccal Insulin Delivery via Hydrophobic Ion-Pairing Approach: In vitro and ex vivo Evaluation.

Authors:  Santosh Bashyal; Jo-Eun Seo; Taekwang Keum; Gyubin Noh; Shrawani Lamichhane; Jeong Hwan Kim; Chang Hyun Kim; Young Wook Choi; Sangkil Lee
Journal:  Int J Nanomedicine       Date:  2021-07-07

Review 8.  Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators.

Authors:  Keith M Olson; John R Traynor; Andrew Alt
Journal:  Front Chem       Date:  2021-10-07       Impact factor: 5.221

Review 9.  Traditional and Computational Screening of Non-Toxic Peptides and Approaches to Improving Selectivity.

Authors:  Alberto A Robles-Loaiza; Edgar A Pinos-Tamayo; Bruno Mendes; Josselyn A Ortega-Pila; Carolina Proaño-Bolaños; Fabien Plisson; Cátia Teixeira; Paula Gomes; José R Almeida
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.